With the introduction of mandatory risk-based assessments, Parachex provides an evidence-based solution that enables vets to remain compliant while saving consultation time and safeguarding practice revenue.
The updated RCVS guidance requires vets to consider a pet’s individual lifestyle, environment, and exposure before prescribing flea, tick, and worm treatments. While the new framework is essential for the sustainable use of parasiticides and environmental protection, it places significant demands on practices. Alongside existing time pressures, vets face the challenge of educating owners who may not yet understand the rationale behind tailored parasite control. In addition, most practice management systems are not specifically designed to manage individual anti-parasitic treatment plans.
Parachex has been designed to respond directly to these challenges. The system enables pet owners to complete a short pre-consultation questionnaire, which is then used to generate a bespoke parasite risk profile. This profile includes clear treatment and faecal testing recommendations, customised to align with each practice’s protocols, preferred antiparasiticide products, and branding. By shifting the information-gathering process outside the consultation, vets are freed to focus on higher-value clinical discussions, while automated reports and prescriptions integrate smoothly into practice workflows.
Rachel Kirkby MRCVS, business development director at VetDX, says “Parachex helps bring parasiticide prescribing back into the consult room, where it supports clear, evidence-based discussions with owners. This not only improves compliance but also protects practice revenue that might otherwise be lost online. The platform also allows practices to evolve their health plans gradually from product-heavy packages to service-led models, safeguarding and diversifying revenue at a time when traditional dispensing strategies are under increasing pressure.”
Alongside its workflow and educational benefits, the platform also helps practices demonstrate their commitment to professional and regulatory standards. Uploadable reports provide clear evidence of responsible prescribing in line with the RCVS Practice Standards Scheme, while its evidence-based framework reflects the BVA’s call for sustainable, risk-based parasite control. In addition, the client-facing plans generated by the system explain both what is prescribed and why, directly supporting the recommendations of the Competition and Markets Authority.
Importantly, Parachex operates with no pharmaceutical alliances and follows a pay-per-use model, ensuring practices retain full autonomy over product choice while keeping costs accessible. The platform also offers a suite of owner education resources, including how-to videos, articles on parasite lifecycles and transmission plus seasonal awareness prompts.
Parachex is now available to veterinary practices across the UK. You can find out more or request a demonstration here or via email.
